BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares of the […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 1,630,000 shares, a growth of 8.7% from the April 30th total of 1,500,000 shares. Based on an average daily trading volume, of 584,400 shares, the days-to-cover […]
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) has been given an average recommendation of “Hold” by the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year […]
BioXcel Therapeutics' (BTAI) "Buy" Rating Reaffirmed at HC Wainwright modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 3,140,000 shares, a decline of 20.9% from the February 29th total of 3,970,000 shares. Currently, 14.6% of the company’s shares are sold short. Based on an […]